UBS AM
AEHR icon

UBS AM’s Aehr Test Systems AEHR Stock Holding History

UBS AM’s Portfolio AEHR Stock Details AEHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.07M Buy
52,815
+18,434
+54% +$1.68M ﹤0.01% 1600
2026
Q1 		$1.27M Buy
34,381
+5,379
+19% +$172K ﹤0.01% 2241
2025
Q4 		$586K Buy
+29,002
New +$701K ﹤0.01% 2291
2024
Q2 		– Sell
-33,566
Closed -$416K – 2798
2024
Q1 		$416K Hold
33,566
– – ﹤0.01% 2337
2023
Q4 		$891K Sell
33,566
-324
-1% -$9.45K ﹤0.01% 2097
2023
Q3 		$1.55M Buy
33,890
+27,190
+406% +$1.26M ﹤0.01% 1739
2023
Q2 		$208K Hold
6,700
– – ﹤0.01% 2564
2023
Q1 		$208K Sell
6,700
-4,700
-41% -$151K ﹤0.01% 2564
2022
Q4 		$229K Buy
+11,400
New +$244K ﹤0.01% 2410

Other funds holding AEHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UBS AM's AEHR Position: Q2 2026 in Review

UBS AM increased its Aehr Test Systems (AEHR) stake by 54% in Q2 2026, buying an estimated $1.68M and bringing the position to 52,815 shares worth $5.07M. The position accounts for ﹤0.01% of the portfolio, ranked #1600.

UBS AM first reported a position in AEHR in Q4 2022 and has held it in 9 quarters since. 262 funds tracked by Wall St. Rank hold AEHR as of Q2 2026.

  • UBS AM held 52,815 shares of Aehr Test Systems worth $5.07M as of Q2 2026.
  • UBS AM bought 18,434 Aehr Test Systems shares in Q2 2026, an estimated $1.68M.
  • Aehr Test Systems made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #1600 holding.
  • UBS AM first reported a position in Aehr Test Systems in Q4 2022 and has held it in 9 quarters since.
  • 262 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.